Reaction Details Report a problem with these data
Target
RAF proto-oncogene serine/threonine-protein kinase [306-648,Y340D,Y341D]
Ligand
BDBM210003
Substrate
n/a
Meas. Tech.
Raf IC50 Assay Protocol
IC50
4.50±n/a nM
Citation
 Zhou, C; Wang, S; Zhang, G Fused tricyclic compounds as Raf kinase inhibitors US Patent  US10576087 Publication Date 3/3/2020 
Target
Name:
RAF proto-oncogene serine/threonine-protein kinase [306-648,Y340D,Y341D]
Synonyms:
C-Raf (Y340D/Y341D) | RAF | RAF1 | RAF1_HUMAN
Type:
n/a
Mol. Mass.:
38958.87
Organism:
Homo sapiens (Human)
Description:
PV3805, from Invitrogen
Residue:
343
Sequence:
SQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSDDWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF
  
Inhibitor
Name:
BDBM210003
Synonyms:
US10576087, Compound 2.9 | US9273046, 2.9 | US9895376, Compound 2.9
Type:
Small organic molecule
Emp. Form.:
C23H17N5O3
Mol. Mass.:
411.4128
SMILES:
O=C1CCc2c(Oc3ccc4OC5C(C5c4c3)c3nc4ccncc4[nH]3)ccnc2N1
Structure:
Search PDB for entries with ligand similarity: